These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10930671)

  • 1. Seroepidemiology of varicella-zoster virus infection in Catalonia (Spain). Rationale for universal vaccination programmes.
    Salleras L; Domínguez A; Vidal J; Plans P; Salleras M; Taberner JL
    Vaccine; 2000 Sep; 19(2-3):183-8. PubMed ID: 10930671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.
    Wiese-Posselt M; Siedler A; Mankertz A; Sauerbrei A; Hengel H; Wichmann O; Poethko-Müller C
    BMC Infect Dis; 2017 May; 17(1):356. PubMed ID: 28525973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of varicella-zoster antibodies in pregnant women in Catalonia (Spain). Rationale for varicella vaccination of women of childbearing age.
    Plans P; Costa J; Espuñes J; Plasència A; Salleras L
    BJOG; 2007 Sep; 114(9):1122-7. PubMed ID: 17666097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.
    Alp H; Altinkaynak S; Ertekin V; Kiliçaslan B; Giiraksin A
    Health Policy; 2005 Apr; 72(1):119-24. PubMed ID: 15760704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella-zoster virus immunity among health care workers in Catalonia.
    Urbiztondo L; Bayas JM; Broner S; Costa J; Esteve M; Campins M; Borrás E; Domínguez A;
    Vaccine; 2014 Oct; 32(45):5945-8. PubMed ID: 25219564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of varicella zoster virus infection in child and adult population of Catalonia (Spain).
    Salleras L; Domínguez A; Plans P; Costa J; Cardeñosa N; Torner N; Plasència A
    Med Microbiol Immunol; 2008 Sep; 197(3):329-33. PubMed ID: 18004592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroepidemiology of Varicella zoster in Israel prior to large-scale use of varicella vaccines.
    Cohen DI; Davidovici BB; Smetana Z; Balicer RD; Klement E; Mendelson E; Green MS
    Infection; 2006 Aug; 34(4):208-13. PubMed ID: 16896579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to varicella zoster virus among young adults: a decline prior to widespread uptake of varicella vaccines.
    Grotto I; Balicer RD; Smetana Z; Davidovitch N; Bar-Zeev Y; Mendelson E; Zarka S; Huerta M
    Infection; 2008 Mar; 36(2):130-4. PubMed ID: 18379727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of varicella-zoster virus in Polish population.
    Siennicka J; Trzcińska A; Rosińska M; Litwińska B
    Przegl Epidemiol; 2009; 63(4):495-9. PubMed ID: 20120946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE changing seroepidemiology of varicella in Japan: 1977-1981 and 2001-2005.
    Ueno-Yamamoto K; Tanaka-Taya K; Satoh H; Araki K; Kaku M; Okabe N
    Pediatr Infect Dis J; 2010 Jul; 29(7):667-9. PubMed ID: 20228693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus.
    Barbosa CM; Terreri MT; Rosário PO; de Moraes-Pinto MI; Silva CA; Hilário MO
    Clin Exp Rheumatol; 2012; 30(5):791-8. PubMed ID: 22935227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of varicella-zoster virus and reliability of varicella history in Turkish children, adolescents and adults.
    Koturoglu G; Kurugol Z; Turkoglu E
    Paediatr Perinat Epidemiol; 2011 Jul; 25(4):388-93. PubMed ID: 21649681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing seroprevalence of varicella zoster virus infection in a tropical city state, Singapore.
    Fatha N; Ang LW; Goh KT
    Int J Infect Dis; 2014 May; 22():73-7. PubMed ID: 24269652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain.
    Plans-Rubió P
    Vaccine; 2004 Sep; 22(29-30):4002-13. PubMed ID: 15364450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of IgG varicella zoster virus antibodies in the Kuikuro and Kaiabi indigenous communities in Xingu National Park, Brazil, before varicella vaccination.
    Lafer MM; de Moraes-Pinto MI; Weckx LY
    Rev Inst Med Trop Sao Paulo; 2005; 47(3):139-42. PubMed ID: 16021286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiology of varicella-zoster virus in Korean adolescents and adults using fluorescent antibody to membrane antigen test.
    Han SB; Kang KR; Huh DH; Lee HC; Kim JH; Kang JH; Ma SH
    Epidemiol Infect; 2015 Jun; 143(8):1643-50. PubMed ID: 25234331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of varicella zoster virus-specific cell-mediated immunity by using an interferon-γ enzyme-linked immunosorbent assay.
    Hayashida K; Ozaki T; Nishimura N; Gotoh K; Funahashi K; Nakane K; Gomi Y; Manabe S; Ishikawa T; Yamanishi K
    J Immunol Methods; 2015 Nov; 426():50-5. PubMed ID: 26232696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.